Active ingredientArotinololCat. No. P-A187-001CAS 68377-92-4Family · Pharmaceutical analytical standards
Arotinolol
A beta blocker with additional alpha-blocking action, first described in Japan in 1979 and in use since the mid-1980s for high blood pressure, angina and arrhythmias. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?In China it is also widely used for essential tremor, the condition that makes the hands shake: a 2025 study found it was the drug most often used by these patients.
Go to the active ingredient →Active ingredientArotinololCat. No. P-A187-001CAS 68377-92-4
Active ingredientArotinolol HClCat. No. P-A187-002CAS 68377-91-3
Isotopically labelledArotinolol-d5 HydrochlorideCat. No. P-A187-003CAS 2514848-16-7
NitrosamineN1-Nitroso ArotinololCat. No. P-A187-004
ImpurityArotinolol Impurity 1Cat. No. P-A187-005CAS 13080-65-4
ImpurityArotinolol intermediate product 8Cat. No. P-A187-006CAS 52560-89-1
ImpurityArotinolol Impurity 2Cat. No. P-A187-007
ImpurityArotinolol Impurity 3Cat. No. P-A187-008
ImpurityArotinolol Impurity 4Cat. No. P-A187-009
ImpurityArotinolol Impurity 5Cat. No. P-A187-010
ImpurityArotinolol Impurity 6 HydrochlorideCat. No. P-A187-011
ImpurityArotinolol Impurity 7Cat. No. P-A187-012
ImpurityArotinolol Impurity 8Cat. No. P-A187-013
ImpurityArotinolol Impurity 9Cat. No. P-A187-014
ImpurityR-Arotinolol HClCat. No. P-A187-015CAS 87055-50-3
ImpurityS-Arotinolol HClCat. No. P-A187-016CAS 101540-26-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.